DECENTRALITATION OF SYNTHESTECH
The goal of further research by “Synthestech” is to adjust the technology and develop precise techniques for Cold Transmutation of chemical elements; techniques that will be commercially profitable and industrially scalable. The work is based on previously obtained data as a result of our own research and on the study results of other scientists engaged in LENR reactions. Three main areas of work are planned:
- Transmutation of low-value starting elements into valuable elements in order to obtain such elements as rhenium, osmium, iridium, platinum, ruthenium, rhodium, palladium and, perhaps, gold;
- Transmutation of low-value starting elements in order to obtain nonstandard isotope mixtures and individual isotopes of stable elements;
- Transmutation of various starting elements in order to obtain bioactive elements for medical purposes with properties, recorded in the sources of ancient Chinese and ancient Indian medicine, as well as in works of the medieval European scientist and doctor Paracelsus.
Researchers are facing the following tasks:
- Analyze in detail the processes occurring in reactions, previously discovered by “Synthestech” group;
- Using the obtained data, select the most technologically and commercially promising methods of transformation of some elements into others, in order to conduct a detailed analysis of the specific Cold Transmutation of chemical elements;
- Develop optimal conditions for a specific LENR-transmutation reaction;
- Create and test different modifications of reactors for Cold Transmutation of chemical elements; elaborate equipment constructions, materials, tools and so on; select optimal ratios of components of reagents mixture;
- Produce a pilot batch of artificially obtained elements.
Technology
Cold Transmutation (LENR) of chemical elements — is a breakthrough, innovative technology for transforming one chemical element into another. Cheap elements into precious ones. It is a possibility of obtaining platinum group metals and other valuable elements, including gold, from cheap raw materials by artificial means. Ability to synthesise chemical elements will change the economy in a much more significant way, compared to even blockchain technology. Phenomenon of Cold Transmutation was discovered in recent decades. Our group is developing this technology; we have conducted hundreds of experiments and achieved phenomenal results. Among those results is obtaining of platinum group metals.
Token Sale Details
We invite partners and investors to join the “Synthestech” laboratory and participate in the Token Generation Event (hereinafter TGE). In the frames of this event, “Synthestech” will issue tokens on the Ethereum platform and sell them to a wide range of investors for bitcoins and ethers. The raised funds will be used for construction of the “Synthestech” laboratory, formation of a global team of specialists and carrying out of researches. “Synthestech” tokens (ticker — STT) are dividend tokens, which give the right to receive 36% of the profit of Swiss Isotopes SARL, registered in Geneva (Switzerland). STT Tokens do not grant shareholder rights, but are provided with 36% of Swiss Isotopes SARL shares through the planned emission of 10,000 investment certificates (working title). 10, 000 certificates are equal to 100% of Swiss Isotopes SARL shares. From a technical point of view, tokens are provided with a smart contract on the Ethereum platform that meets the ERC-20 standard and investors can store them in different wallets and services.
- Commercial name of the project: Synthestech
- Name of Token: Synthestech Token, (Ticker STT)
- Token price: 1 STT is equal to 1 USD
- Unsold tokens will be reserved by the Issuer and will be later put up for sale.
Posting Komentar
0 Komentar